(Q51393045)

English

Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.

scientific article published in February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22052584

Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol. (English)

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22052584

author name string

Saima Chohan

1

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22052584

Michael A Becker

2

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22052584

Patricia A MacDonald

3

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22052584

Solomon Chefo

4

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22052584

Robert L Jackson

5

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22052584

publication date

1 February 2012

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22052584

Arthritis Care and Research

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22052584

64

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22052584

2

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22052584

256-261

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22052584

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

1 reference

https://api.crossref.org/works/10.1002%2FACR.20680

21 January 2018

Pathogenesis of Gout

1 reference

https://api.crossref.org/works/10.1002%2FACR.20680

21 January 2018

Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase

1 reference

https://api.crossref.org/works/10.1002%2FACR.20680

21 January 2018

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

1 reference

https://api.crossref.org/works/10.1002%2FACR.20680

21 January 2018

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial

1 reference

https://api.crossref.org/works/10.1002%2FACR.20680

21 January 2018

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

1 reference

https://api.crossref.org/works/10.1002%2FACR.20680

21 January 2018

Preliminary criteria for the classification of the acute arthritis of primary gout

1 reference

https://api.crossref.org/works/10.1002%2FACR.20680

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1002%2FACR.20680

21 January 2018

Sex differences in gout epidemiology: evaluation and treatment

1 reference

https://api.crossref.org/works/10.1002%2FACR.20680

21 January 2018

Identifiers

10.1002/ACR.20680

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22052584

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/22052584

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51393045&oldid=932376058"